Cell Source, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Cell Source, Inc. (CLCS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 750.00 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-08-08.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-08-08
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 750.00K shares, a 44.44% decline from fiscal 2021.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 1.35M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2022-12-31 | 750.00K shares 10-K · filed 2023-08-08 |
| 2021-12-31 | 1.35M shares 10-K · filed 2022-04-15 |